AOD9604 is a synthetic peptide fragment derived from the C-terminal region of human growth hormone. It is designed to retain targeted research-related bioactivity while excluding the growth-promoting effects associated with full-length GH. This peptide is widely adopted in preclinical research programs investigating lipid metabolism, fat breakdown regulation and energy balance. In laboratory studies, AOD9604 is shown to stimulate lipolysis and inhibit lipogenesis in adipose tissue models, supporting research into body composition modulation. It does not trigger significant IGF-1 elevation in most research models, which makes it a popular candidate for comparative peptide studies. Our AOD9604 is manufactured via solid-phase peptide synthesis, purified with preparative high-performance liquid chromatography. Every production batch is validated by HPLC and mass spectrometry to confirm identity, purity and minimal impurity content. The lyophilized powder format stabilizes the peptide structure, preventing degradation during transit and long-term cold storage. Once reconstituted with suitable aqueous solvents, the solution can be applied for in vitro cell assays and animal model research.